Global Antidepressant Drugs Market: Opportunities and Forecasts (2018-2023) - PowerPoint PPT Presentation

Loading...

PPT – Global Antidepressant Drugs Market: Opportunities and Forecasts (2018-2023) PowerPoint presentation | free to download - id: 896bfb-YjM3N



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Global Antidepressant Drugs Market: Opportunities and Forecasts (2018-2023)

Description:

A comprehensive research report that analyses the antidepressant drugs market and the drugs market by Class. For more mail: info@azothanalytics.com – PowerPoint PPT presentation

Number of Views:19

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Global Antidepressant Drugs Market: Opportunities and Forecasts (2018-2023)


1
Global Antidepressant Drugs Market Analysis By
Drugs Class, By Sales Channel, By Region, By
Country Opportunities and Forecasts (2018-2023)
  • By Drugs Class - Tricyclic Antidepressants,
    Selective Serotonin Reuptake Inhibitors,
    Selective -Norepinephrine Reuptake Inhibitors,
    Monoamine Oxidase Inhibitors , Benzodiazepines.
    Antipsychotics, Novel Agents
  • By Sales Channel - Hospital Clinics, Retail
    Pharmacies, Others
  • By Region- APAC , North America, Europe and RoW
  • By Country - United States, Canada, United
    Kingdom, Germany, , China, India, Japan, Brazil,
    South Arabia

February 2018
2
Global Antidepressant Drugs Market Analysis By
Drugs Class, By Sales Channel, By Region, By
Country Opportunities and Forecasts (2018-2023)
- By Region (APAC , N. America, Europe , RoW),
By Country (US, Canada, UK, Germany, China,
India, Japan, Brazil, South Arabia)
  • Global Coverage
  • Regional Coverage
  • Country Coverage
  • By Drugs Class
  • By Sales Channels
  • Scope of the Study
  • Region (North America, Europe, APAC, Rest of
    World )
  • Country (U.S., Canada, Germany, United Kingdom,
    India, China, Japan, Brazil, South Arabia)

Regional Coverage
Company Coverage
Country Coverage
Global Coverage
  • North America
  • Europe
  • Asia Pacific
  • Rest of World
  • PFIZER INC.
  • ELI LILLY
  • Allergan
  • Novartis
  • Takeda
  • GlaxoSmithkiline
  • Forest Laboratories
  • U.S.
  • Canada
  • Germany
  • United Kingdom
  • India
  • China
  • Japan
  • Brazil
  • South Arabia
  • Anti Depressants Drugs Market By Value (In USD
    Billion) -(2013-2023)
  • By Drugs Class ( Tricyclic, Serotonin-Norepinephri
    ne Inhibitors, Antipsychotics, Selective Srotonin
    Reuptake Inhibitors, Benzodiazepines, Monoamine
    Oxidase Inhibitors, Novel Agents, Others)
  • By Sales Channels (Hospitals Clinics, Retail
    Pharmacies, Others)
  • Antidepressant Drugs Market By Value
    (2013-2023)
  • Segmentation By Drugs Class
  • Segmentation By Sale Channels
  • Anti Depressant Drugs Market By Value (In USD
    Billion) -(2013-2023)
  • Breakdown-By - Drugs Class (2013-2023)
  • Product Benchmarking
  • Business Overview
  • Pipeline Analysis

2
3
Table of Content
S.No Particulars Particulars Particulars Page No.
1. Research Methodology Research Methodology Research Methodology 18
2. Executive Summary Executive Summary Executive Summary 19
3. Strategic Recommendation Strategic Recommendation Strategic Recommendation 20
3.1 Focus on Asia Pacific Region Focus on Asia Pacific Region 21
3.2 Focus on new antidepressant drugs development Focus on new antidepressant drugs development 22
4. Antidepressant Drugs Market Outlook Antidepressant Drugs Market Outlook Antidepressant Drugs Market Outlook 23
5. Global Antidepressant Drugs Market Growth and Forecast Global Antidepressant Drugs Market Growth and Forecast Global Antidepressant Drugs Market Growth and Forecast 28
5.1 By Value (2013-2017) By Value (2013-2017) 29
5.2 By Value (2018-2023) By Value (2018-2023) 34
6. Global Antidepressant Drugs Market By Drugs Class Global Antidepressant Drugs Market By Drugs Class Global Antidepressant Drugs Market By Drugs Class 35
6.1 Global Antidepressant Drugs Market-By Drugs Class Breakdown() Global Antidepressant Drugs Market-By Drugs Class Breakdown() 35
6.1.1 Global Antidepressant Drugs Market Size and Share, By Drugs, 2017 36
6.1.2 Global Antidepressant Drugs Market Size and Share, By Drugs, 2023 37
6.2 Global Selective Serotonin Reuptake Inhibitors Market Overview Global Selective Serotonin Reuptake Inhibitors Market Overview 38
6.2.1 By Value (2013-2023) 38
3
4
Table of Content
S. No Particulars Particulars Page No.
6.3 Global Serotonin and Norepinephrine Reuptake Inhibitors Market Overview Global Serotonin and Norepinephrine Reuptake Inhibitors Market Overview 42
6.3.1 By Value (2013-2023) 42
6.4 Global Monoamine Oxidase Inhibitors Market Overview Global Monoamine Oxidase Inhibitors Market Overview 44
6.4.1 By Value (2013-2023) 44
6.5 Global Tricyclic Antidepressant Drugs Market Overview Global Tricyclic Antidepressant Drugs Market Overview 46
6.5.1 By Value (2013-2023) 46
6.6 Global Benzodiazepines Antidepressant Drugs Market Overview Global Benzodiazepines Antidepressant Drugs Market Overview 48
6.6.1 By Value (2013-2023) 48
6.7 Global Antipsychotics Antidepressant Drugs Market Overview Global Antipsychotics Antidepressant Drugs Market Overview 50
6.7.1 By Value (2013-2023) 50
6.8 Global Novel Agents Antidepressant Drugs Market Overview Global Novel Agents Antidepressant Drugs Market Overview 52
6.8.1 By Value (2013-2023) 52
6.9 Global Other Antidepressant Drugs Market Overview Global Other Antidepressant Drugs Market Overview 53
6.9.1 By Value (2013-2023) 53
7. Global Antidepressant Drugs Market By Sales Channels Global Antidepressant Drugs Market By Sales Channels Global Antidepressant Drugs Market By Sales Channels 54
7.1 Global Antidepressant Drugs Market-By Sales Channels Breakdown() Global Antidepressant Drugs Market-By Sales Channels Breakdown() 54
7.1.1 Global Antidepressant Drugs Market Size and Share, By Sales Channels, 2017 55
7.1.2 Global Antidepressant Drugs Market Size and Share, By Sales Channels, 2023 56
4
5
Table of Content
S. No Particulars Particulars Particulars Page No.
7.2 Global Antidepressant Drugs Market By Hospital Clinics Overview Global Antidepressant Drugs Market By Hospital Clinics Overview Global Antidepressant Drugs Market By Hospital Clinics Overview 57
7.2.1 By Value (2013-2023) By Value (2013-2023) 57
7.3 Global Antidepressant Drugs Market By Retail Pharmacies Overview Global Antidepressant Drugs Market By Retail Pharmacies Overview Global Antidepressant Drugs Market By Retail Pharmacies Overview 58
7.3.1 By Value (2013-2023) By Value (2013-2023) 58
7.4 Global Antidepressant Drugs Market By Others Overview Global Antidepressant Drugs Market By Others Overview Global Antidepressant Drugs Market By Others Overview 59
7.4.1 By Value (2013-2023) By Value (2013-2023) 59
8. Global Antidepressant Drugs Market Pipeline Analysis Global Antidepressant Drugs Market Pipeline Analysis Global Antidepressant Drugs Market Pipeline Analysis Global Antidepressant Drugs Market Pipeline Analysis 60
8.1 By Developer, Phase, Indication and Status By Developer, Phase, Indication and Status By Developer, Phase, Indication and Status 61
9. Global Antidepressant Drugs Market Regional Analysis Global Antidepressant Drugs Market Regional Analysis Global Antidepressant Drugs Market Regional Analysis Global Antidepressant Drugs Market Regional Analysis 65
9.1 Global Antidepressant Drugs Market, By Region Breakdown () Global Antidepressant Drugs Market, By Region Breakdown () Global Antidepressant Drugs Market, By Region Breakdown () 65
9.1.1 Global Antidepressant Drugs Market Size, By Region, 2017 () Global Antidepressant Drugs Market Size, By Region, 2017 () 66
9.1.2 Global Antidepressant Drugs Market Size, By Region, 2023 () Global Antidepressant Drugs Market Size, By Region, 2023 () 67
9.2 North America Antidepressant Drugs Market An Analysis North America Antidepressant Drugs Market An Analysis North America Antidepressant Drugs Market An Analysis 68
9.2.1 By Value (2013-2017) By Value (2013-2017) 69
9.2.2 By Value (2018-2023) By Value (2018-2023) 70
9.3 North America Antidepressant Drugs Market Segment Analysis North America Antidepressant Drugs Market Segment Analysis North America Antidepressant Drugs Market Segment Analysis 71
9.3.1 North America Antidepressant Drugs Market By Drug Class North America Antidepressant Drugs Market By Drug Class 72
9.3.1.1 North America Antidepressant Drugs Market Size, By Value, 2013-2023 72
9.3.2 North America Antidepressant Drugs Market By Sales Channels North America Antidepressant Drugs Market By Sales Channels 74
9.3.2.1 North America Antidepressant Drugs Market Size, By Value, 2013-2023F 75
5
6
Table of Content
S. No Particulars Particulars Particulars Page No.
9.4 North America Antidepressant Drugs Market Country Analysis (U.S. and Canada) North America Antidepressant Drugs Market Country Analysis (U.S. and Canada) North America Antidepressant Drugs Market Country Analysis (U.S. and Canada) 76
9.4.1 U.S. Antidepressant Drugs Market, By Value (2013-2023) U.S. Antidepressant Drugs Market, By Value (2013-2023) 79
9.4.1.1 U.S. Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 84
9.4.2 Canada Antidepressant Drugs Market, By Value (2013-2023) Canada Antidepressant Drugs Market, By Value (2013-2023) 87
9.4.2.2 Canada Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 89
9.5 Europe Antidepressant Drugs Market An Analysis Europe Antidepressant Drugs Market An Analysis Europe Antidepressant Drugs Market An Analysis 91
9.5.1 By Value (2013-2017) By Value (2013-2017) 92
9.5.2 By Value (2018-2023) By Value (2018-2023) 93
9.6 Europe Antidepressant Drugs Market Segment Analysis Europe Antidepressant Drugs Market Segment Analysis Europe Antidepressant Drugs Market Segment Analysis 94
9.6.1 Europe Antidepressant Drugs Market By Drugs Class Europe Antidepressant Drugs Market By Drugs Class 94
9.6.1.1 Europe Antidepressant Drugs Market Size, By Value, 2013-2023 95
9.6.2 Europe Antidepressant Drugs Market By Sales Channels Europe Antidepressant Drugs Market By Sales Channels 97
9.6.2.1 Europe Antidepressant Drugs Market Size, By Value, 2013-2023F 98
9.7 Europe Antidepressant Drugs Market Country Analysis (U.K., Germany Rest of Europe) Europe Antidepressant Drugs Market Country Analysis (U.K., Germany Rest of Europe) Europe Antidepressant Drugs Market Country Analysis (U.K., Germany Rest of Europe) 99
9.7.1 United Kingdom Antidepressant Drugs Market, By Value (2013-2023) United Kingdom Antidepressant Drugs Market, By Value (2013-2023) 102
9.7.1.1 United Kingdom Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 106
9.7.2 Germany Antidepressant Drugs Market, By Value (2013-2023) Germany Antidepressant Drugs Market, By Value (2013-2023) 109
9.7.2.1 Germany Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 112
9.7.3 Rest of Europe Antidepressant Drugs Market, By Value (2013-2023) Rest of Europe Antidepressant Drugs Market, By Value (2013-2023) 114
6
7
Table of Content
S. No Particulars Particulars Particulars Page No.
9.8 Asia Pacific Antidepressant Drugs Market An Analysis Asia Pacific Antidepressant Drugs Market An Analysis Asia Pacific Antidepressant Drugs Market An Analysis 115
9.8.1 By Value (2013-2017) By Value (2013-2017) 116
9.8.2 By Value (2018-2023) By Value (2018-2023) 117
9.9 Asia Pacific Antidepressant Drugs Market Segment Analysis Asia Pacific Antidepressant Drugs Market Segment Analysis Asia Pacific Antidepressant Drugs Market Segment Analysis 118
9.9.1 Asia Pacific Antidepressant Drugs Market By Drugs Class Asia Pacific Antidepressant Drugs Market By Drugs Class 118
9.9.1.1 Asia Pacific Antidepressant Drugs Market Size, By Value, 2013-2023 119
9.9.2 Asia Pacific Antidepressant Drugs Market By Sales Channels Asia Pacific Antidepressant Drugs Market By Sales Channels 121
9.9.2.1 Asia Pacific Antidepressant Drugs Market Size, By Value, 2013-2023F 122
9.10 Asia Pacific Antidepressant Drugs Market Country Analysis (Germany, U.K., Rest of Europe) Asia Pacific Antidepressant Drugs Market Country Analysis (Germany, U.K., Rest of Europe) Asia Pacific Antidepressant Drugs Market Country Analysis (Germany, U.K., Rest of Europe) 123
9.10.1 India Antidepressant Drugs Market, By Value (2013-2023) India Antidepressant Drugs Market, By Value (2013-2023) 126
9.10.1.1 India Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 130
9.10.2 China Antidepressant Drugs Market, By Value (2013-2023) China Antidepressant Drugs Market, By Value (2013-2023) 133
9.10.2.1 China Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 136
9.10.3 Japan Antidepressant Drugs Market, By Value (2013-2023) Japan Antidepressant Drugs Market, By Value (2013-2023) 140
9.10.3.1 Japan Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 143
9.10.4 Rest of Asia Pacific Antidepressant Drugs Market, By Value (2013-2023) Rest of Asia Pacific Antidepressant Drugs Market, By Value (2013-2023) 145
7
8
Table of Content
S. No Particulars Particulars Particulars Page No.
9.11 Rest of World Antidepressant Drugs Market An Analysis Rest of World Antidepressant Drugs Market An Analysis Rest of World Antidepressant Drugs Market An Analysis 146
9.11.1 By Value (2013-2017) By Value (2013-2017) 147
9.11.2 By Value (2018-2023) By Value (2018-2023) 148
9.12 Rest of World Antidepressant Drugs Market Segment Analysis Rest of World Antidepressant Drugs Market Segment Analysis Rest of World Antidepressant Drugs Market Segment Analysis 149
9.12.1 Rest of World Antidepressant Drugs Market By Drugs Class Rest of World Antidepressant Drugs Market By Drugs Class 149
9.12.1.1 Rest of World Antidepressant Drugs Market Size, By Value, 2013-2023 150
9.12.2 Rest of World Antidepressant Drugs Market By Sales Channels Rest of World Antidepressant Drugs Market By Sales Channels 152
9.12.2.1 Rest of World Antidepressant Drugs Market Size, By Value, 2013-2023F 153
9.13 Rest of World Antidepressant Drugs Market Country Analysis (Brazil, Saudi Arabia Others) Rest of World Antidepressant Drugs Market Country Analysis (Brazil, Saudi Arabia Others) Rest of World Antidepressant Drugs Market Country Analysis (Brazil, Saudi Arabia Others) 154
9.13.1 Brazil Antidepressant Drugs Market, By Value (2013-2023) Brazil Antidepressant Drugs Market, By Value (2013-2023) 157
9.13.1.1 Brazil Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 158
9.13.2 Saudi Arabia Antidepressant Drugs Market, By Value (2013-2023) Saudi Arabia Antidepressant Drugs Market, By Value (2013-2023) 161
9.13.2.1 Saudi Arabia Antidepressant Drugs Market, By Drugs Class, By Value (2013-2023) 162
9.13.3 Others Antidepressant Drugs Market, By Value (2013-2023) Others Antidepressant Drugs Market, By Value (2013-2023) 164
8
9
Table of Content
S. No Particulars Page No.
10. Market Dynamics Market Dynamics 165
10.1 Drivers 166
10.2 Challenges 169
11. Market Trends Market Trends 171
12. Policy and Regulatory Landscape Policy and Regulatory Landscape 173
13. Porters Five Forces Analysis Antidepressant Drugs Market Porters Five Forces Analysis Antidepressant Drugs Market 181
14. SWOT Analysis Antidepressant Drugs Market SWOT Analysis Antidepressant Drugs Market 183
15. Company Profiling Company Profiling 185
15.1 Allergan 186
15.2 Eli Lilly 187
15.3 Pfizer 188
15.4 Takeda 190
15.5 GlaxoSmithKline 192
15.6 Novartis 193
15.7 Forest Laboratories 195
16. About Us About Us 196
9
10
List of Figures
Figure No. Figure Title Page No.
Figure 1 Global Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 29
Figure 2 Global YLDs of Depressive Disorders (2013-2016, ) 30
Figure 3 Global DALYs of Anxiety Disorders (2013-2016 ) 30
Figure 4 DALYs due to Mental and Substance Abuse (2016) 30
Figure 5 World Female Population, 2012-2016 (Million) 31
Figure 6 World Population 65 Years Above ( of Total), 2012-2016 31
Figure 7 Global Unemployment (2016, 2017E, 2018F, (Millions) 32
Figure 8 Global Health Expenditure Per Capita, By Select Countries,(2016, USD) 33
Figure 9 Global Health Expenditure Per Capita, (2012-2016, USD Trillion) 33
Figure 10 Global Antidepressant Drugs Market Size, By Value, 2018-2023 (USD Billion) 34
Figure 11 Global Antidepressant Drugs Market Size, By Drugs, 2017 () 36
Figure 12 Global Antidepressant Drugs Market Size, By Drugs Class, 2023F () 37
Figure 13 Global Selective Serotonin Reuptake Inhibitors Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) 38
Figure 14 Global Selective Serotonin Reuptake Inhibitors Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) 38
Figure 15 SSRIs Antidepressants Usage in Different Disorders () 40
Figure 16 Global Serotonin and Norepinephrine Reuptake Inhibitors Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) 42
Figure 17 Global Serotonin and Norepinephrine Reuptake Inhibitors Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) 42
Figure 18 Global Monoamine Oxidase Inhibitors Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) 44
Figure 19 Global Monoamine Oxidase Inhibitors Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) 44
10
11
List of Figures
Figure No. Figure Title Page No.
Figure 20 Global Tricyclic Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) 46
Figure 21 Global Tricyclic Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) 46
Figure 22 Global Benzodiazepines Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) 48
Figure 23 Global Benzodiazepines Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) 48
Figure 24 Global Antipsychotics Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) 50
Figure 25 Global Antipsychotics Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) 50
Figure 26 Global Novel Agents Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) 52
Figure 27 Global Novel Agents Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) 52
Figure 28 Global Others Antidepressant Drugs Market, By Value, 2013-2017 (USD Billion) 53
Figure 29 Global Others Antidepressant Drugs Market, By Value, 2018E-2023F (USD Billion) 53
Figure 30 Global Antidepressant Drugs Market Size, By Sales Channels, 2017 () 55
Figure 31 Global Antidepressant Drugs Market Size, By Sales Channels, 2023 () 56
Figure 32 Global Antidepressant Drugs Market, By Hospital and Clinics, By Value, 2013-2017 (USD Billion) 57
Figure 33 Global Antidepressant Drugs Market, By Hospital and Clinics, By Value, 2018E-2023F (USD Billion) 57
Figure 34 Global Antidepressant Drugs Market, By Retail Pharmacies, By Value, 2013-2017 (USD Billion) 58
Figure 35 Global Antidepressant Drugs Market, By Retail Pharmacies, By Value, 2018E-2023F (USD Billion) 58
Figure 36 Global Antidepressant Drugs Market, By Others, By Value, 2013-2017 (USD Billion) 59
Figure 37 Global Antidepressant Drugs Market, By Others, By Value, 2018E-2023F (USD Billion) 59
Figure 38 Global Antidepressant Drugs Market Size and Share, By Region, 2017 66
Figure 39 Global Antidepressant Drugs Market Size and Share, By Region, 2023F 67
11
12
List of Figures
Figure No. Figure Title Page No.
Figure 40 North America Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 69
Figure 41 North America Antidepressant Drugs Market Size, By Value, Forecast, 2018-2023 (USD Billion) 70
Figure 42 North America Antidepressant Drugs Market By Drugs Class, By Value, 2013-2023 (USD Billion) 72
Figure 43 North America Antidepressant Drugs Market By Sales Channels, By Value, 2013-2023 (USD Billion) 75
Figure 44 North America Antidepressant Drugs Market, Country Share, 2017 ( of Total) 77
Figure 45 North America Antidepressant Drugs Market, Country Share, 2023 ( of Total) 77
Figure 46 United States Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 79
Figure 47 United States Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 79
Figure 48 United States YLDs by Anxiety Disorders (2013-2016 ) 80
Figure 49 United States YLDs by Depressive Disorders (2013-2016 ) 80
Figure 50 United States Prevalence of Different Types of Mental Disorders Among Different Age Group (2016) 80
Figure 51 United States Prevalence of Different Types of Mental Disorders Among Different Age Group (2016) 81
Figure 52 Treatment Received Among Adults with Major Depressive Episode (2016) 81
Figure 53 Per Capita Healthcare Expenditure in United States (2012-2016, USD) 82
Figure 54 U.S Health Spending by Type of Service or Product, 2016 () 82
Figure 55 U.S Health Spending by Type of Service or Product, 2016 () 84
Figure 56 Canada Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 87
Figure 57 Canada Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 87
Figure 58 Canada Antidepressant Drugs Market By Drugs Class, By Value, 2013-2023 (USD Billion) 89
Figure 59 Europe Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 92
Figure 60 Europe Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 93
12
13
List of Figures
Figure No. Figure Title Page No.
Figure 61 Europe Antidepressant Drugs Market By Drugs Class, By Value, 2013-2023 (USD Billion) 95
Figure 62 Europe Antidepressant Drugs Market By Sales Channels, By Value, 2013-2023 (USD Billion) 98
Figure 63 Europe Antidepressant Drugs Market, Country Share, 2017 ( of Total) 100
Figure 64 Europe Antidepressant Drugs Market, Country Share, 2023 ( of Total) 100
Figure 65 United Kingdom Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 102
Figure 66 United Kingdom Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 102
Figure 67 United Kingdom YLDs by Depressive Disorders (2013-2016 ) 103
Figure 68 Antidepressant Dispensed in England (2005, 2015, 2016, Million Units) 103
Figure 69 United Kingdom YLDs by Anxiety Disorders (2013-2016 ) 103
Figure 70 Per Capita Healthcare Expenditure in United Kingdom (2012-2016, USD) 104
Figure 71 U.K. Population 65 Years Above ( of Total), 2012-2016 104
Figure 72 United Kingdom Antidepressant Drugs Market By Drugs Class, By Value, 2013-2023 (USD Billion) 106
Figure 73 Germany Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 109
Figure 74 Germany Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 109
Figure 75 Private Healthcare Spending in Germany, US Dollar/capita (2012-2016) 110
Figure 76 Germany Per Capita Healthcare Expenditure (2012-2016, USD) 110
Figure 77 Germany YLDs DALYs by Depressive Disorders (2013-2016 ) 110
Figure 78 Germany Antidepressant Drugs Market By Drugs Class, By Value, 2013-2023 (USD Billion) 112
Figure 79 Rest of Europe Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 114
Figure 80 Rest of Europe Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 114
13
14
List of Figures
Figure No. Figure Title Page No.
Figure 81 Asia Pacific Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 116
Figure 82 Asia Pacific Antidepressant Drugs Market Size, By Value, Forecast, 2018-2023 (USD Billion) 117
Figure 83 Asia Pacific Antidepressant Drugs Market By Drugs Class, By Value, 2013-2023 (USD Billion 119
Figure 84 Asia Pacific Antidepressant Drugs Market By Sales Channels, By Value, 2013-2023 (USD Billion) 122
Figure 85 Asia Pacific Antidepressant Drugs Market, Country Share, 2017 ( of Total) 124
Figure 86 Asia Pacific Antidepressant Drugs Market, Country Share, 2023 ( of Total) 124
Figure 87 India Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 126
Figure 88 India Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 126
Figure 89 Prevalence of Depressive Disorders in India By Age and Sex- (2015-2016) 127
Figure 90 India Healthcare Expenditure (2012-2016, USD Billion) 128
Figure 91 India Antidepressant Drugs Market By Drugs Class, By Value, 2013-2023 (USD Billion) 130
Figure 92 China Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 134
Figure 93 China Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 134
Figure 94 China YLDs by Anxiety Disorders (2013-2016 ) 135
Figure 95 China YLDs DALYs by Depressive Disorders (2013-2016 ) 135
Figure 96 China Healthcare Expenditure (2012-2016, USD Billion) 136
Figure 97 China Population 65 Years Above ( of Total), 2012-2016 136
Figure 98 China Antidepressant Drugs Market By Drugs Class, By Value, 2013-2023 (USD Billion) 137
Figure 99 Japan Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 140
Figure 100 Japan Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 140
14
15
List of Figures
Figure No. Figure Title Page No.
Figure 101 Japan Per Capita Health Expenditure (2012-2016, USD) 141
Figure 102 Japan YLDs by Depressive Disorders (2013-2016 ) 141
Figure 103 Japan YLDs by Depressive Disorders (2013-2016 ) 141
Figure 104 Japan Antidepressant Drugs Market By Drugs Class, By Value, 2013-2023 (USD Billion) 143
Figure 105 Rest of Asia Pacific Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 145
Figure 106 Rest of Asia Pacific Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 145
Figure 107 Rest of World Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 147
Figure 108 Rest of World Antidepressant Drugs Market Size, By Value, Forecast, 2018-2023 (USD Billion) 148
Figure 109 Rest of World Antidepressant Drugs Market By Drugs Class, By Value, 2013-2023 (USD Billion) 150
Figure 110 Rest of World Antidepressant Drugs Market By Sales Channels, By Value, 2013-2023 (USD Billion) 153
Figure 111 Rest of World Antidepressant Drugs Market, Country Share, 2017 ( of Total) 155
Figure 112 Rest of World Antidepressant Drugs Market, Country Share, 2023 ( of Total) 155
Figure 113 Brazil Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 157
Figure 114 Brazil Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 157
Figure 115 Brazil Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 158
Figure 116 Saudi Arabia Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 161
15
16
List of Figures
Figure No. Figure Title Page No.
Figure 117 Saudi Arabia Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 162
Figure 118 Saudi Arabia Antidepressant Drugs Market By Drugs Class, By Value, 2013-2023 (USD Billion) 162
Figure 119 Others Antidepressant Drugs Market Size, By Value, 2013-2017 (USD Billion) 164
Figure 120 Others Antidepressant Drugs Market Size, By Value, 2018E-2023F (USD Billion) 164
Figure 121 Pfizer Segmental Breakup, 2016 () 189
Figure 122 Pfizer Sales, By Region, 2016 () 189
Figure 123 Takeda Segmental Break Up 191
Figure 124 Takeda Geographical Break Up 191
Figure 125 Novartis Sales, By Segment 2015 () 194
Figure 126 Novartis Sales, By Region, 2015 () 194
Figure 127 Novartis Pharmaceuticals Sales, By Franchise, 2015 () 194
16
17
List of Tables
Table No. Table Title Page No.
Table A List of Major Antidepressant Drugs Include in SSRIs Class 39
Table B Licenced Indication of SSRIs 41
Table C List of Major Antidepressant Drugs Include in SNRIs Class 43
Table D List of Major Antidepressant Drugs Include in MAOIs Class 45
Table E List of Major Antidepressant Drugs Include in Tricyclic Class 47
Table F List of Major Antidepressant Drugs Include in Tetracyclic Class 47
Table G List of Major Antidepressant Drugs Include in Benzodiazepines 48
Table H List of Major Antidepressant Drugs Include in Antipsychotics 51
Table I Antidepressant Drugs Market Analysis, By Drug, Developer, Phase, Indication 61
Table J Facts and Figures Driving High Demand of Antidepressants in United States Market 81
17
18
Research Methodology
Azoth Analytics has conducted quantitative as
well as qualitative research to gather market
insights such as market sizing, market
segmentation, recent trends and developments and
competitive landscape. Our team has conducted
extensive primary surveys by reaching out
industry experts across the value chain of the
global orthopeadic market.
Companies Contacted Apollo Pharmacy
18
19
Global Antidepressant Drugs Market Overview
Global Antidepressant Drugs Market has been
driven by rising prevalence of depression and
anxiety disorders worldwide
Figure Global Antidepressant Drugs Market
Size, By Value, 2013-2017 (USD Billion)
CAGR 2013-2017 xxxx
Source Azoth Analytics Estimates
  • Xxxx
  • Xxxx
  • Xxxx
  • Xxxx
  • Xxxx
  • Xxxx
  • xxxx

19
20
Global Monoamine Oxidase Inhibitors
Antidepressant Drugs  Market Overview
Figure Global Monoamine Oxidase Inhibitors
Antidepressant Drugs Market, By Value,
2018E-2023F (USD Billion)
Figure Global Monoamine Oxidase Inhibitors
Antidepressant Drugs Market, By Value, 2013-2017
(USD Billion)
CAGR 2013-2017 xx
CAGR 2018-2023 xx
Source Azoth Analytics Estimates
  • Xxxxx
  • Xxxxx
  • Xxxxx
  • Xxxxx
  • Xxxxx
  • xxxxx

20
21
Global Antidepressant Drugs Market - By Sales
Channels
In the forecast period, Retail Pharmacies are
expected to account for the largest share in the
market (45.34) but the Other segment
estimated to be the faster growing region.
Figure Global Antidepressant Drugs Market Size,
By Sales Channels, 2023 ()
Source Azoth Analytics Estimates
21
22
Germany Antidepressant Drugs Market, By Drugs
Class
CAGR 2013-2017 TCAs xx SSRIs xx SNRIs
xx MAOIs xx Benzodiazepines xx
Antipsychotics xx Novel Agents xx Others
xx
CAGR 2018-2023 TCAs xx SSRIs xx SNRIs
xx MAOIs xx Benzodiazepines xx
Antipsychotics xx Novel Agents xx Others
xx
Source Azoth Analytics Estimates
22
23
United States Antidepressant Drugs Market, By
Drugs Class
CAGR 2013-2017 TCAs 1.82 SSRIs 2.75 SNRIs
2.82 MAOIs 1.83 Benzodiazepines 2.26
Antipsychotics 0.73 Novel Agents 3.22
Others3.30
CAGR 2018-2023 TCAs 2.42 SSRIs 3.20 SNRIs
3.23 MAOIs 2.36 Benzodiazepines 0.23
Antipsychotics 0.57 Novel Agents 3.73
Others5.78
Source Azoth Analytics Estimates
23
24
Global Antidepressant Drugs Market Analysis By
Drugs Class, By Sales Channel, By Region, By
Country Opportunities and Forecasts (2018-2023)
-- By Region (APAC, N. America, Europe, RoW), By
Country (US, Canada, UK, Germany, China, India,
Japan, Brazil, South Arabia) Publish Date Feb
2018 No. of Pages 195 Price USD 2400 (Single
User License) Price USD 3000 (Multi- User
License) To View Sample Report or Purchase
Report Click Here
Contact Us
ASIA PACIFIC

EUROPE


Mail info_at_azothanalytics.com

Mail shipra_at_azothanalytics.com
Phone 91 120 429 8235

Phone 44 - 744 - 8107625
NORTH AMERICA

Call for Assistance


Mail tanvi_at_azothanalytics.com

Phone 91 9873 4262
88Phone 1 - 321 - 444 9707

Sales Enquiry  


Phone 91 120
429 8235
www.azothanalytics.com
24
25
About Azoth Analytics Pvt Ltd. Azoth Analytics
is a business research and analytics firm that
creates in-depth research reports and provides
customized research solutions and consultancy
services. Verticals in which Azoth Analytics
specializes include healthcare and
pharmaceutical, oil and gas, retail, chemicals,
automotive, FMCG, food beverages and
technology. Azoth creates comprehensive and
in-depth research reports by recording,
interpreting and analyzing information. Strategic
market sizing and data dredging techniques
include secondary research, and primary research
(interviews with management personnel and
industry experts). Related Reports Global
Vitreoretinal Surgery Devices Market (By Product,
By End User, By Region, By Country)
Opportunities and Forecast (2016-2021) By
Product (Vitrectomy Machines Packs,
Photocoagulation Surgery Devices, Illumination
Devices, Others) By End User (Hospitals, Free
Standing Ambulatory Surgery Center) By Region
(North America, Europe, APAC, ROW) By Country
(US, Canada, Mexico, UK, Germany, France, Japan,
China, India, Brazil, South Africa) Global
Biomaterials Market (By Type, By Applications, By
Region) Opportunities and Forecasts (2016-2021)
- (By Material Type Polymer, Ceramic, Metal By
Appliactions - Orthopaedic, Cardiovascular,
Plastic Surgery, Wound Care) By Region-North
America, Europe, APAC, ROW By Country US, UK,
Germany, Italy, Japan, China, India Key Players
Strategy, Financial Performance) Disclaimer
Azoth Analytics report information is based
mainly on interviews and therefore, is subject to
fluctuation. Azoth Analytics therefore, takes no
responsibility for any incorrect information
supplied to us by industry experts, manufacturers
or users. Azoth does not warranty the
completeness of the information and data. Also,
analysis provided in the report are meant for
customers internal use only and not for general
publication or disclosure to third parties.
24
About PowerShow.com